Our Team

Eyman Metanis MPH


Eyman has been involved in building and running many successful international businesses since 2008. Eyman holds a Masters in Public Health Administration and has a vast knowledge of the pharmaceutical industry. Eyman has spent the majority of the last decade growing his companies into successful ventures.

Dr Omar Said PHD


Dr. Omar is the Chief Research Officer and founder of BELEAF PHARMA. Dr. Omar is a pioneer and an expert in the field of Greco-Arab medicine and herbal medicine pharmacology. Dr. Omar has published numerous scientific publications in pharmacology and other fields, and is a recognized expert on the translation of ancient manuscripts. Dr. Omar holds a Doctor of Science degree in Pharmacology.

Craig Lavoie


With over 15 years of sales and management experience, Craig joined the BELEAF PHARMA team in 2018 as the Chief Operating Officer. Involved since the beginning, Craig has played a role in every aspect of building BELEAF PHARMA to where it is today. From overseeing international operations, supply chain management, and product design to licensing, legal, and marketing.

Dr Stephen Fulder

Dr Fulder is an internationally recognized expert in the fields of medicinal plants and indigenous medicine. Dr Fulder holds a degree in biochemistry from Oxford University and a doctorate on gerontology from the National Institute of Medical Research in London, England. Dr. Fulder has written 11 books on herbs and has published many scientific papers.

Matej Breznik PHD

With a PHD in Pharmacology, Matej has a lot of experience in the pharmaceutical industry. He has held various positions including senior management in pharmaceutical drug companies as well as being the General Manager of JAZMP, the regulator body for Slovenia.

Muhamad Abbas

Muhamad Abbas, B. Sc., has spent his career as an environmental researcher and advisor in the field of life sciences and environmental protection. With a passion for environmental focused regulations, Muhamad brings a fresh perspective to the BeLeaf team as he oversees product regulations regionally.

Professor Bashar Saed

Professor of cell biology and immunology at the Arab American University in Jenin, PA and acts as director of the Qasemi Research Center – Al Qasemi Academic College. His research interests include anti-inflammatory and anticancer properties of medicinal plants. He is the author of the first academic book about Arab and Islamic herbal medicine published by John Wiley in 2011. He is a member of the editorial board of Evidence-based Alternative and Complementary Medicine (eCAM).

Dr. Ahmad Yazbak

Dr. Ahmad Yazbak is a leading senior researcher at the R&D center in Isreal and for the past 3 years, has project managed a regional cooperation project funded by a $ 1 million grant from USAID focusing on acting Olive Mill Wastewater in the Middle East. With a Ph.D. in Chemistry from the Technion-Israel Institute of Technology, Dr. Yazbak has published numerous works focusing on chemical synthesis and the use of chemistry in alternative medicine.

Professor Iyad Khamaysi


Professor Iyad Khamaysi currently directs the Advanced Endoscopy Unit for the Department of Gastroenterology at the Rambam Health Care Campus. Professor Khamaysi is an industry-leading instructor within the field of Gastroenterology.
Professor Khamaysi is a member of numerous national and international medical societies. He also serves as a scientific consultant for numerous hospitals, medical centers, and medical start-up companies.

Riyad Amin


Riyad Amin is a professor of biochemistry and has 40 years of experience in clinical biochemistry. He has served as a professor of biochemistry for 22 years, took up the Fulbright Award in 1987, and spent 18 years serving as Chairman of a  Biochemistry Department 

His research concentrates on natural products and disease management. During his career Riyad participated in three clinical trials in the United States as Sub-Investigator evaluating the safety and efficacy of various drugs for treating: Chronic Obstructive Pulmonary Disorder (COPD), Irritable Bowel Syndrome (IBS) and Hypertension.